Home › Targets › telomerase
telomerase (2 companies · 10 programs)
Companies with an active program directed at telomerase.
- ateganosine — Non-Small Cell Lung Cancer Phase 3
- ateganosine — Hepatocellular Carcinoma Phase 2
- ateganosine — Colorectal Cancer Phase 2
- ateganosine — Pediatric-Type Diffuse High-Grade Glioma Preclinical
- MAIA-2021-20 Preclinical
- MAIA-2022-12 Preclinical
- MAIA-2021-029 Preclinical
- RYTELO — Myelodysplastic Syndromes Approved
- RYTELO — Myelofibrosis Phase 3
- imetelstat — Acute Myeloid Leukemia Phase 2
